Guilin Sanjin Pharmaceutical (002275.SZ) distributed 2.5 yuan per 10 shares in the first three quarters, with the ex-dividend date on November 25th.

Guilin Sanjin Pharmaceutical (002275.SZ) announced that the company will implement the distribution of equity for the first three quarters of 2024, for every 1...

Zhitong FinanceNov 18 19:13

Express News | guilin sanjin pharmaceutical: The sales of the Sanjin tablets have gradually caught up, and the sales of the Watermelon Frost series are also slowly recovering.

BreakingsNov 13 16:55

guilin sanjin pharmaceutical (002275): steady growth with obvious signs of recovery

Event: In the first three quarters of 2024, the company achieved revenue of 1.575 billion yuan (-3.49% year-on-year, the same below), achieving a net income attributable to the parent company of 0.384 billion yuan (-3.28%), achieving a non-recurring net income attributable to the parent company

Debang SecuritiesOct 31 15:22

Guilin Sanjin: Report for the third quarter of 2024

SZSIOct 30 00:00 · Announcements

Guilin Sanjin Pharmaceutical (002275.SZ): The net income for the first three quarters was 0.384 billion yuan, a 3.28% year-on-year decrease.

Guilin Sanjin Pharmaceutical (002275.SZ) announced its third quarter report for 2024 on October 29. In the first three quarters of 2024, the company achieved revenue of 1.575 billion yuan, a decrease of 3.49% year-on-year; net income attributable to the shareholders of the listed company was 0.384 billion yuan, a decrease of 3.28% year-on-year; net income after deducting non-recurring gains and losses was 0.347 billion yuan, a decrease of 7.78% year-on-year; basic earnings per share were 0.65 yuan per share.

Gelonghui FinanceOct 29 19:34

Guilin Sanjin Pharmaceutical (002275.SZ): The actual controller and chairman of the company has completed the shareholding plan, with a cumulative shareholding of 0.383 million shares.

Guilin SanJin (002275.SZ) announced on September 2nd that the company disclosed the "Announcement on the Shareholding Plan of the Actual Controller, Chairman, and CEO of the Company" on March 2, 2024. Mr. Zou Xun, the actual controller, chairman, and CEO of the company, plans to use his own funds to increase his shareholding in the company through centralized bidding or bulk trading on the Shenzhen Stock Exchange within six months starting from March 2, 2024. The amount of shareholding increase shall not be less than 5 million RMB. From March 2, 2024 to September 1, 2024, Mr. Zou Xun has cumulatively increased his shareholding through centralized bidding on the Shenzhen Stock Exchange.

Gelonghui FinanceSep 2 15:58